SmartPill™ Motility Capsule

Product Details

The SmartPill™ motility capsule assists in localizing transit abnormalities to a specific GI region by collecting data from the entire GI tract. As the SmartPill™ motility capsule travels through the patient's GI tract, it measures pressure, pH and temperature to provide you with valuable diagnostic information, including gastric emptying and total GI transit times in your patients. 

Order Information

HOW TO ORDER

For additional information or to place an order, please call Customer Service at +44 (0) 19 2320 2504.

Order Information
Order Code Description Unit of Measure Quantity
FGS-0503 SmartPill™ capsules (includes 5 SmartBars & 5 patient brochures)
Pack 5

MotiliGI™ Software

Product Details

MotiliGI™ software provides data analysis tools, offering physicians a variety of test reporting and exporting options to aid in the identification of motility disorders. The software calculates gastric emptying time, small bowel transit time, colonic transit time, combined small/large bowel transit time, and whole gut transit time in graphical and statistical formats, and presents this data in a summary report.

SmartPill™ Motility Recorder

Product Details

The SmartPill™ motility recorder records gastric emptying time, colonic transit time, combined small/large bowel transit time, and whole gut transit time, stores all captured data points, and transfers to SmartPill™ software for analysis.

Order Information

HOW TO ORDER

For additional information or to place an order, please call Customer Service at +44 (0) 19 2320 2504.

Order Information
Order Code Description Unit of Measure Quantity
50100500 SmartPill™ Data Recorder (includes 5-pack of lanyards and belt clips) Each 1
957900 VersaFlex VNIS+US Catheter - VNIS+US Disposable Bifurcated pH Catheters, Internal Reference, Catheter 1 & 2 both Single Channel, (4.7FR), 10/pkg Each 1

Overview

Evaluate unexplained GI motility disorders

The SmartPill™ motility testing system calculates colonic transit time for the evaluation of colonic transit in patients with chronic constipation and differentiation of slow and normal transit constipation. The system also measures combined small and large bowel transit time, which is used as a surrogate measure of colonic transit in patients with chronic constipation when colonic transit time alone cannot be determined.

  • The only motility test that provides a complete transit profile of the gastrointestinal tract
  • Increased sensitivity compared to Gastric Emptying Scintigraphy (GES) and Radio Opaque Markers (ROM)([FOOTNOTE=Kuo, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2008;27:186-196.],[ANCHOR=],[LINK=])
  • Ability to localize disease to specific regions of the GI tract in the presence of overlapping motility symptoms([FOOTNOTE=Rao, et al. Evaluation of gastrointestinal transit in clinical practice: Position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil. 2011;23(1):8-23.],[ANCHOR=],[LINK=])
  • Standardized motility testing process with benchmarked results1

Technology

Innovative motility testing

The SmartPill™ motility testing system localizes abnormalities in specific areas of the GI tract in the presence of overlapping motility symptoms. This advanced system allows you to understand the root cause of your patients' motility disorders and helps you develop appropriate therapy plans. With user-friendly SmartPill™ software, analyzing study results is simple and convenient.

The SmartPill™ motility capsule detected a generalized motility disorder in 51% of patients and influenced management in 30% of patients with lower GI disorders and 88% of patients with upper GI disorders.

  • Reduces testing by replacing three tests([FOOTNOTE=Moshiree B. Case Presentation Illustrating Use of Wireless Motility Capsule. 2010 Joint International Neurogastroenterology and Motility Conference.],[ANCHOR=],[LINK=])
  • Whole gut motility profile eliminates the need for segmental transit studies3
  • Can replace GES, ROM, and Whole Gut Scintigraphy3
  • Can reduce the cost of separate procedures and associated facility fees by 50%